Cell panel profiling of pre-clinical and clinical anti-cancer agents reveals conserved therapeutic clusters and differentiates the mechanism of action of different PI3K/mTOR, Aurora kinase and EZH2 inhibitors

著录项

• 来源
  《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2016年第null期|共1页
• 作者

  Uitdehaag J. C. M.; De Roos J. A. D. M.; Prinsen M. B. W.; Willemsen-Seegers N.; De Vetter J. R. F.; Dylus J.; Van Doornmalen A. M.; Kooijman J.; Sawa M.; Van Gerwen S. J. C.; De Man J.; Buijsman R. C.; Zaman G. J. R.;

  展开▼
• 作者单位

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词